This article explains how state-led regulatory sandbox programs are shaping the development of AI governance in the United States, highlighting how controlled testing environments are influencing liability, oversight, and the future of real-world AI deployment.
This article analyzes Utah’s state-approved pilot allowing AI to autonomously renew certain prescription medications, explaining how the program tests regulatory boundaries between administrative automation and medical judgment and why its outcomes could influence healthcare AI policy nationwide.